Nwbo Short Interest A Short Squeeze is when a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest by purchasing actual shares, which in turn drives the. Short interest is updated twice per month per FINRA. NWBO is not currently paying a regular dividend. 15¢ (April 21, 2020) Smith on Stocks. NWBO is a $1+ billion biotech company that develops personalized immune therapies for cancer in the US and internationally. After every published short interest release, the data is compiled and made available for members to download and use (in Excel format). Latest Dividend N/A Ex-Dividend Date N/A Short Interest () N/A Stock Money Flow N/A COMPETITORS ( NWBO) Research &. Watch list Create NWBO Alert Closed Last Updated: Dec 2, 2022 4:00 p. Northwest Biotherapeutics Inc (NWBO) 0 No Notifications Add to Watchlist Add to Portfolio Quotes Summary Real-Time Feb 17, 2023 10:19 am 0 Previous Close $0. Short Interest Most Shorted Stocks These are the companies with the largest proportions of outstanding shares currently sold short. The Northwest Biotherapeutics stock price gained 0. Monday April 3, 2023 20 Min Delayed Short Quote™ Symbol: Short Quote™ In The News. No short interest data for NWBO. 83M: Short % of Shares Out 1. About Northwest Biotherapeutics Inc. May 03, 2023 (Alliance News via COMTEX) -- The Emerging Cancer Vaccines market document additionally mentions market share gathered by means of every product. Short Interest: 5. Northwest Biotherapeutics (NWBO) News Today $0. Will the SEC fail to hold those MMs accountable to the NWBO shareholders? Also, legitimate short interest has climbed again above 40M shares as of 2/28/23. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. View NWBO revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. About Northwest Biotherapeutics Inc. Short Interest Charts for OTCPK:NWBO Access to some data is restricted for this account tier. Northwest Biotherapeutics Inc is a biotechnology company involved in. Short interest for Northwest Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of Northwest Biotherapeutics's stock. Northwest Biotherapeutics Inc. Stocktwits - The largest community for investors and traders /topic/NWBO. 79 million shs Market Capitalization $650. Dec 21, 2022 5:46 AM EST Micro-cap company Creatd has been taking steps to protect its shareholders from abusive trading practices such as naked short selling. NWBO is not currently paying a regular dividend. What are NWBO key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of. Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. , a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. I highly recommend all NWBO investors brush up on their story over at r/Superstonk because our monster (Citadel) is the same. Here's some detail on a new $15mn loan they received: On November 22, 2021, Northwest Biotherapeutics, Inc. (NWBO) stock, including valuation metrics, financial numbers, share information and more. Short interest is updated twice per month per FINRA. Use historical perspective as a guide for valuable trading research. Short Interest: 5. Where will these shorts get the shares to cover? NWBO shares failed to be delivered - 32M+ in the past 12 months. Full Income Statement Balance Sheet. So, suppose investors can accurately measure the market's sentiment. Northwest Biotherapeutics (NWBO) News Today $0. Short Interest Charts for OTCPK:NWBO Access to some data is restricted for this account tier. It dives into the trial; the epic interim results from the combo trials; the short interest and more: 21 Mar 2023 19:39:18. After Hours trades will be posted from 4:15 p. stock news by MarketWatch. com table with short interest data for the last several months, includes short interest, average daily volume and days to cover. Northwest Biotherapeutics Stock (OTC: NWBO) stock price, news, charts, stock research, profile. Profile News Analyst Ratings Guidance Dividends Earnings Insider Trades Ideas Short Interest. Short interest, short volume, short sales, borrow availability and fee rate. Northwest Biotherapeutics (NWBO) Competitors $0. We are looking at game changing news in the coming months. The company was founded in 1996 and is headquartered in Bethesda, Maryland. NWBO | Complete Northwest Biotherapeutics Inc. 04 ( Switch to: Reports Actions News Y-Rating Valuation More Price Chart Price Returns View Full Chart Key Stats View All Stats Risk Show Comparables Show Benchmark 3Y 5Y 10Y 15Y all Edit comparables Upgrade now. The target is a broad range of solid-tumor cancers. NWBO | Complete Northwest Biotherapeutics Inc. Open short interest can be seen. 02 Quality, Value, Momentum Scores. The borrow rate (fee rate to borrow shares) and rebate rate are updated every 15 minutes each market day. The mission of ShortSqueeze® is to provide short interest stock market data and services, so our members will be better informed of short selling in the market, track short interest in stocks, and gain from the advantages of this powerful market data. $NWBO Short Interest & Failed-To-Deliver Data $NWBO Failed-To-Deliver data for 2H February shows another 0. research and ratings by Barron's. When expressed as a percentage, short interest is the number of shorted shares divided by the number of shares outstanding. Update Frequency: Twice Monthly. Short Interest N/A % of Float Shorted N/A. Northwest Biotherapeutics, Inc. Short Interest N/A % of Float Shorted N/A Average Volume 1. No short interest data for NWBO. Charts and comments are provided for interest and discussion for those who share a common passion for trading. NWBO went up over $2 in May when the company reported primary data at the New York Academy of Sciences. It has been mired in controversies, and it has no cash. The company's current value of PPandE Turnover is estimated at 0. NWBO : 0. Some of his more recent analyses can be found below. Rising short interest is usually viewed as a bearish indicator, however, like so many other indicators, it can be a contrarian indicator at extremes. Stat: Northwest Bio Study Of Brain Cancer Vaccine Still Falls Short Northwest Biotherapeutics tried again, but its experimental treatment for brain cancer still falls short. $NWBO Short Interest & Failed-To-Deliver Data $NWBO Failed-To-Deliver data for 2H February shows another 0. NWBO short interest (days to cover the shorts) ratio is 13. 99 (Updated Daily) APE Short Squeeze Score: N/A Related: Antara Cashes Out a Whopping $72. Re: BreezeWoodAcres post# 589412. NWBO went up over $2 in May when the company reported primary data at the New York Academy of Sciences. And to use a four-word opinion - those results were outstanding. Reported short interest on mmtlp as of Oct 31, 2022 has been released. 22 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Chart. Short Interest Charts for OTCPK:NWBO Access to some data is restricted for this account tier. NorthWest Biotherapeutics Inc (NWBO) Reply Private New Keep Last Read Replies (1) Next 10 Prev Next aesop1 aesop1 Re: hoffmann6383 post# 584249 Tuesday, April 11, 2023 12:08:10 PM Post # of. News View All News Headline Wire Time (ET). The borrow rate (fee rate to borrow shares) and rebate rate are updated every 15 minutes each market day. Reported short interest on mmtlp as of Oct 31, 2022 has been released. Gain from this comprehensive collection of rich content - updated and available now for immediate access. To top it off, $NWBO has been shorted to shit, and assailed by hedefund hit pieces, decimating the stock price. Full data, including history older than 9 months and the most up-to-date information, is only available with an ORTEX Advanced Subscription. 94%) Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market FinancialNewsMedia - Wed Oct 21, 2020 Palm Beach, FL – October 21, 2020 – Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical companies. $NWBO Short Interest & Failed-To-Deliver Data $NWBO Failed-To-Deliver data for 2H February shows another 0. About Northwest Biotherapeutics Inc. Northwest Biotherapeutics PPandE Turnover is quite stable at the moment as compared to the past year. Detailed statistics for Northwest Biotherapeutics, Inc. Northwest Biotherapeutics, Inc. (the "Company") entered into a loan financing with Streeterville Capital, LLC (the. NorthWest Biotherapeutics Inc (NWBO) Reply Private New Keep Last Read Replies (1) Next 10 Prev Next aesop1 aesop1 Re: hoffmann6383 post# 584249 Tuesday, April 11, 2023 12:08:10 PM Post # of. During the last trading day the stock fluctuated 3. The mission of ShortSqueeze® is to provide short interest stock market data and services, so our members will be better informed of short selling in the market, track short interest in stocks, and gain from the advantages of this powerful market data. Short interest stock data available for. Northwest Biotherapeutics Inc (NWBO) 0 No Notifications Add to Watchlist Add to Portfolio Quotes Summary Real-Time Feb 17, 2023 10:19 am 0 Previous Close $0. The key change is the Primary Outcome and Secondary Outcome. Is Northwest Biotherapeutics' short interest increasing or decreasing?. NWBO has the potential to be a $100B revenue generating company with immunotherapy, which is an area that many BP do not even have a foothold in yet. After every published short interest release, the data is compiled and made available for members to download and use (in Excel format). Prior to this, the last update was given in October 2016. The Northwest Biotherapeutics stock price gained 0. 4800 MONTGOMERY LANE SUITE 800, BETHESDA, Maryland, 20814, United States +1 240 497-9024. NWBO short interest - , number of shares short, days to cover, percent of float, short ratio, short selling NWBO NWBO Short Interest Data. NWBO shares currently have a short interest ratio of 12. 6775 Key Data Bid Price and Ask Price. Barunuuk • 1 mo. Tuesday, April 11, 2023 12:08:10 PM. ago I believe NWBO has been shorted similar to DNDR to either bankrupt them or keep them low to be bought out cheaper. It develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s immune system to attack cancer. The stock garners more short interest than the average industry, sector or S&P 500 stock. Short Interest Charts for OTCPK:NWBO Access to some data is restricted for this account tier. Institutional interest is still quite low, at just. The data are updated twice per month around mid-month and at the end of the month. Naked Short Interest PLPL - Short Volume Report (REGSHO) All RegSho Dated reported by: FINRA Regular Volume Short Volume Mar 15 Mar 23 Mar 31 Apr 11 Mar 20 Mar 28 Apr 05 0 50,000,000 100,000,000 150,000,000 200,000,000 Highcharts. Short Interest: Short Float: 3. The Northwest Biotherapeutics stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. Larry Smith is a long-time long shareholder, and well-known biotech analys in NWBO and has reported often on the stock. 83M: Short % of Shares Out 1. The mission of ShortSqueeze® is to provide short interest stock market data and services, so our members will be better informed of short selling in the market, track short interest. About Northwest Biotherapeutics Inc. Short Interest 14. Short Interest 14. Latest Dividend N/A Ex-Dividend Date N/A Short Interest () N/A Stock Money Flow N/A COMPETITORS ( NWBO) Research & Ratings Northwest. NorthWest Biotherapeutics Inc (NWBO) Message Board - Company Name: NorthWest Biotherapeutics Inc, Stock Symbol: NWBO, Industry: Biotechs - Total Posts: 591395 - Last Post: 05/06/2023 11:15:50. Short Interest Change: N/A: Percent. Friday, April 28, 2023 3:05:35 PM. The Northwest Biotherapeutics stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of. NWBO - Short squeeze stock short interest data and short selling information for shares of Northwest Biotherapeutics Incorporated. Each report includes a comprehensive collection of in-depth short interest details. After 20 years of waiting, Northwest Biotherapeutics ( OTCQB:NWBO) declared results last week. In 2014 Larry Smith was first aware of short selling going on with regards to NWBO and described, how NWBO was short attacked and he coupled that with influence of Adam Feuerstein, at that time writing for TheStreet. Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of. Naked Short Interest PLPL - Short Volume Report (REGSHO) All RegSho Dated reported by: FINRA Regular Volume Short Volume Mar 15 Mar 23 Mar 31 Apr 11 Mar 20 Mar 28. More NWBO News InvestorsHub NewsWire CGAC Completes $894,325 Purchase of 412 Bitcoin Miners, Mining Operations Underway • CGAC • Apr 28, 2023 8:30 AM UC Asset Rated "Buy" by Independent Analyst. Re: BreezeWoodAcres post# 589412. 48% ) Upgrade to Real-Time Quote Board Chart Level 2 News Trades. NWBO short interest (days to cover the shorts) ratio is 13. r/Shortsqueeze• $BBIG - Latest ORTEX data shows 20% Short interest with over 55 million shares on loan. See NWBO short interest ratio chart. NWBO investors might be well advised to consider that the Company's stock price is an algorithm endowed with unlimited capital , so the NWBO stock price can be set at any price, but currently $0. Northwest Biotherapeutics Inc (NWBO) Historical Data | Nasdaq Historical Quotes: NWBO Edit my quotes Northwest Biotherapeutics Inc (NWBO) Add to Watchlist Add to Portfolio Quotes Summary. Short Interest is the total number of open short positions of a security. NWBO | Complete Northwest Biotherapeutics Inc. A Short Squeeze is when a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest by purchasing actual shares, which in turn drives the price up even further. In fact, Citadel (Ken Griffin , owner ) designates the price of every trade. 48%: Short Ratio (days to cover) 13. (NWBO) Latest Pre Market Trades | Nasdaq Pre-Market: NWBO Edit my quotes Northwest Biotherapeutics Inc (NWBO) DATA AS OF Jun 13, 2022 Add to Watchlist Add to Portfolio Quotes Summary. Short interest refers to the total number of shares sold as a percentage of a company’s total outstanding shares. 5 million shares sold short and 10. It's reported less than 4% of shorts covered. Short interest stock data available for NASDAQ, NYSE, AMEX, OTCBB and Pink Sheets stocks available from shortsqueeze. The latest short interest is 14. This card shows the Quality, Value, and Momentum scores for the company March 20, 2023 /PRNewswire/ - Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid. Yet the stock had a rollercoaster. His website offers a good deal more analysis. Northwest Biotherapeutics, Inc. NorthWest Biotherapeutics Inc (NWBO) Reply Private New Keep Last Read Replies (1) Next 10 Prev Next aesop1 aesop1 Re: hoffmann6383 post# 584249 Tuesday, April 11, 2023 12:08:10 PM Post # of. 14bn and a cash reserve of just $9. Will the SEC fail to hold those MMs accountable to the NWBO shareholders? Also, legitimate short interest has climbed again above 40M shares as of 2/28/23. Northwest Biotherapeutics (NWBO) Stock Forecast, Price & News $0. Northwest Biotherapeutics Short Interest Northwest Biotherapeutics Inc (NWBO) 0. I highly recommend all NWBO investors brush up on their story over at r/Superstonk because our monster (Citadel) is the same. We have provided this information in one convenient place from exchanges such as NYSE, NASDAQ, and CBOE. Northwest Biotherapeutics Inc is a biotechnology company involved in. Short Interest Change: N/A: Percent of. 52-Week High - $2. NWBO - Short squeeze stock short interest data and short selling information for shares of Northwest Biotherapeutics Incorporated. If a stock has a short interest ratio of 10%, then it means that for every 10 outstanding shares, one is held as a short. After 20 years of waiting, Northwest Biotherapeutics ( OTCQB:NWBO) declared results last week. NWBO | Complete Northwest Biotherapeutics Inc. NWBO - , stock quotes, stock charts, news, financials, short interest, message boards, insiders, holders, calendars, competitors, historical quotes, option quotes. Each report includes a comprehensive collection of in-depth short interest details. Short Interest N/A % of Float Shorted N/A. Northwest Biotherapeutics Inc (NWBO) 0. Latest Dividend N/A Ex-Dividend Date N/A Short Interest () N/A Stock Money Flow N/A COMPETITORS ( NWBO) Research & Ratings Northwest. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. Short Interest Northwest Biotherapeutics Stock (OTC:NWBO), Quotes and News Summary Northwest Biotherapeutics Stock (OTC: NWBO) stock price, news, charts, stock research, profile. aesop1: Short squeeze like this TOP happens on these low floaters. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Full data, including history older than 9 months and the most up-to-date information,. 0217 this year, although the value of Receivables Turnover will most likely fall to 7. NWBO Share Price and News / Northwest Biotherapeutics Inc (OTC) EXTENDED Overview Chart Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast Overview CEO: Linda Powers Phone: 12404979024 4800 Montgomery Ln Ste 800 Bethesda, Maryland 20814-3676 Basic Stats Value Mgmt Effectiveness Short Interest. In the same time the stock has climbed 400%. Short Interest Institutional Holdings Insider Activity SEC Filings Revenue EPS NWBO NWBO AFTER HOURS QUOTE NWBO After-Hours Quotes After-Hours Trades See More Trades Investors may trade. 38%) (As of 05/3/2023 ET) Compare Today's Range $0. 80 million shs Market Capitalization $597. This treatment has over 3400 active patients, and made $144mn in Q4 revenue this year. 00%) USD | OTCM | Apr 21, 16:00 Switch to: Reports Actions Quote Performance Key Stats Financials Estimates News Events Y-Rating Valuation Northwest Biotherapeutics Short Interest Short Interest Chart View Short Interest for NWBO. Income Statement In the last 12 months, NWBO had revenue of $1. 67M Performance Analyst Ratings Sell Under Hold Over Buy Number of Ratings 1 Full Ratings Recent News MarketWatch Dow Jones Major. Northwest Biotherapeutics Short Interest Northwest Biotherapeutics Inc (NWBO) 0. Now that they have their TLD in JAMA, the stock is just up to $1. All stocks I have ever owned, the open short interest works well. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. NWBO shares are trading down $0. Stocktwits - The largest community for investors and traders /topic/NWBO. View NWBO business summary and company performance, for a clear financial breakdown. Short interest is updated twice per month per FINRA. Short Interest Download: All short interest stock data Updated for over 16,000 stocks NASDAQ®, NYSE®, AMEX® & OTCBB® Members receive short data 1 - 3 days before NASDAQ's publication release date! Plus, historical data for powerful research Short Squeeze™ Proprietary Data Find powerful squeezes happening now!. NWBO - Short squeeze stock short interest data and short selling information for shares of Northwest Biotherapeutics Incorporated. Keep believing in the naked short interest brother. Short interest is generally expressed as a percentage of the number of shorted shares divided by the total outstanding shares. Northwest Biotherapeutics Inc (NWBO) Historical Data | Nasdaq Historical Quotes: NWBO Edit my quotes Northwest Biotherapeutics Inc (NWBO) Add to Watchlist Add to Portfolio Quotes Summary. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. Short Interest is the total number of open short positions of a security. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers. Where will these shorts get the shares to cover?. NWBO has a market cap of $1. No short interest data for NWBO. 14M: Short Previous Month 13. NWBO went up over $2 in May when the company reported primary data at the New York Academy of Sciences. Also, legitimate short interest has climbed again above 40M shares as of 2/28/23. 4 Million in APE Shares Daily Market News FrankNez – Daily Market News and stock updates. Will the SEC fail to hold those MMs accountable. org Short Interest in NWBO. $NWBO Short Interest & Failed-To-Deliver Data $NWBO Failed-To-Deliver data for 2H February shows another 0. Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. Short interest is updated twice per month per FINRA. Short Interest: Upgrade: Percent of Shares Outstanding Short: Upgrade: Jul '20. The mission of ShortSqueeze® is to provide short interest stock market data and services, so our members will be better informed of short selling in the market, track short interest in stocks, and gain from the advantages of this powerful market data. NWBO investors might be well advised to consider that the Company's stock price is an algorithm endowed with unlimited capital , so the NWBO stock price can be set at any price, but currently $0. 35 million shs Average Volume 1. Short Interest Northwest Biotherapeutics Stock (OTC:NWBO), Quotes and News Summary Northwest Biotherapeutics Stock (OTC: NWBO) stock price, news, charts, stock research, profile. But, the short squeeze, post bid, could push the stock to $50 temporarily. In depth view into NWBO (Northwest Biotherapeutics) stock including the latest price, news, dividend history, earnings information and financials. See NWBO short interest ratio chart. ago I believe NWBO has been shorted similar to DNDR to either bankrupt them or keep them low to be bought out cheaper. 51 (October 20, 2020) 52-Week Low -. Accounts Payable Turnover is expected to rise to 0. Also, legitimate short interest has climbed again above 40M shares as of 2/28/23. On May 12, NWBO must have submitted changes to their Trial Summary on this website: www. The latest short interest is 14. More NWBO News InvestorsHub NewsWire CGAC Completes $894,325 Purchase of 412 Bitcoin Miners, Mining Operations Underway • CGAC • Apr 28, 2023 8:30 AM UC Asset Rated "Buy" by Independent Analyst. Keep track of the officially reported short interest for all of your stocks here. It offers DCVax technology platform, which uses activated. Short interest is updated twice per month per FINRA. Short Interest Most Shorted Stocks These are the companies with the largest proportions of outstanding shares currently sold short. 00%) USD | OTCM | Apr 21, 16:00 Switch to: Reports Actions Quote Performance Key Stats Financials Estimates News Events Y-Rating Valuation Northwest Biotherapeutics Short Interest Short Interest Chart View Short Interest for NWBO. (Feuerstein, 11/21) Stat: Merck To Acquire Imago, Adding Drugs For Bone Marrow Diseases. NWBO Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 13 Institutional Holders 987,244 Total Shares Held 1 Back to NWBO Overview Institutional Holdings. Northwest Biotherapeutics, Inc. The stock garners more short interest than the average industry, sector or S&P 500 stock. The borrow rate (fee rate to borrow shares) and rebate rate are updated every 15 minutes each market day. Northwest Biotherapeutics Short Interest Northwest Biotherapeutics Inc (NWBO) 0. 34%: Short % of Float 1. 34% of the outstanding shares have been sold short. 00%) USD | OTCM | Apr 21, 16:00 Switch to: Reports Actions Quote Performance Key. Ticker is pending news on valuation, merger and Q2 & Q3 earnings. Hi Mike, nice video! I'm not sure whether you have read it already, but if not check out my NWBO synopsis here on Reddit. Support: 888-992-3836 Home NewsWire Subscriptions. Short Interest is the total number of open short positions of a security. Northwest Biotherapeutics PPandE Turnover is quite stable at the moment as compared to the past year. Northwest Biotherapeutics Inc (NWBO) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Monday April 3, 2023 20 Min Delayed Short Quote™ Symbol: Short Quote™ In The News. Rising short interest is usually viewed as a bearish indicator, however, like so many other indicators, it can be a contrarian indicator at. Our data come from many places. To top it off, $NWBO has been shorted to shit, and assailed by hedefund hit pieces, decimating the stock price. $NWBO Short Interest & Failed-To-Deliver Data $NWBO Failed-To-Deliver data for 2H February shows another 0. 93 Short Interest Ratio: 12. Post# of 580657 GoNet,net:NWBO might be bought by 7/15/22 for $10-$20. According to the company's CEO. Northwest Biotherapeutics, Inc. NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers. 48%: Short Ratio (days to cover) 13. Short Interest 14. The product portfolio includes product candidates such as DCVax-L, for patients with. aesop1. Northwest Biotherapeutics Inc is a biotechnology company involved in. Post# of 580657 GoNet,net:NWBO might be bought by 7/15/22 for $10-$20. This one has a miniscule 2m float and a decent sized short interest 300k short. What are NWBO key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?. View real-time stock prices and stock quotes for a full financial overview. NWBO is a $1+ billion biotech company that develops personalized immune therapies for cancer in the US and internationally. And they are fighting back against the shorters for spoofing and naked short sales. 2mn as of the latest reported quarter. In other news, per a recent 8-K, the company acquired a loan of around $11mn non-dilutive. NWBO - Stock Price, News, Charts, Message Board, Trades (NWBO) NWBO Northwest Biotherapeutics Inc (QB) 0. detailed financials by Barron's. This by no means constitute investment/trading advice. NWBO is not currently paying a regular dividend. Short interest for Northwest Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of Northwest Biotherapeutics's stock. com Historical Short Volume Data for PLPL. 14M: Short Previous Month 13. Short Interest. NWBO has a market cap of $1. NWBO Short Interest Data Nasdaq. Where will these shorts get the shares to cover?. 85%) (As of 04/18/2023 12:00 AM ET) Compare Today's Range $0. Northwest Biotherapeutics Inc (NWBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Northwest Biotherapeutics' short interest history, or implied volatility extrapolated from Northwest Biotherapeutics options trading. Here it is, short and sweet and to the point: Just a day before the publication, Sentinus, LLC took a large position in NWBO. Short Interest is the total number of open short positions of a security. Profile Chart Competitors Earnings Financials Headlines SEC Filings Short Interest About Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Northwest. In 2014 Larry Smith was first aware of short selling going on with regards to NWBO and described, how NWBO was short attacked and he coupled that with influence of Adam Feuerstein, at that time writing for TheStreet. Short Interest (Prior Shares Short) 112,300 % From 52-Wk High ($ 36. stock news by MarketWatch. Even though their situation is different than ours (naked short selling vs spoofing), individual shorting tactics work in a broader inter-related way to move markets for the benefit of the hedgies. Dec 21, 2022 5:46 AM EST Micro-cap company Creatd has been taking steps to protect its shareholders from abusive trading practices such as naked short selling. Here it is, short and sweet and to the point: Just a day before the publication, Sentinus, LLC took a large position in NWBO. NWBO has the potential to be a $100B revenue generating company with immunotherapy, which is an area that many BP do not even have a foothold in yet. NWBO Share Price and News / Northwest Biotherapeutics Inc (OTC) EXTENDED Overview Chart Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast Overview CEO: Linda Powers Phone: 12404979024 4800 Montgomery Ln Ste 800 Bethesda, Maryland 20814-3676 Basic Stats Value Mgmt Effectiveness Short Interest. 0200% on the last trading day (Monday, 1st May 2023), rising from $0. A Short Squeeze is when a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest by purchasing actual shares, which in turn drives the price up even further. So, suppose investors can accurately measure the market's sentiment. Northwest Bioth operates under Biotechnology classification in the United States and is traded on OTC Exchange. : OTC Northwest Biotherapeutics Inc. For example, a company with a 10% short interest might have 10. com and his boss Jim Cramer at that time participated in an interview, where he described the shorting techniques to manipulate …. 53 million P/E Ratio N/A Dividend Yield N/A Price Target N/A. Short interest for Northwest Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of Northwest Biotherapeutics's. Hi Mike, nice video! I'm not sure whether you have read it already, but if not check out my NWBO synopsis here on Reddit. 76 million shs Average Volume 1. In that case, they can use it for their benefit. Short Interest N/A % of Float Shorted N/A Average Volume 1. Naked Short Interest PLPL - Short Volume Report (REGSHO) All RegSho Dated reported by: FINRA Regular Volume Short Volume Mar 15 Mar 23 Mar 31 Apr 11 Mar 20 Mar 28 Apr 05 0 50,000,000 100,000,000 150,000,000 200,000,000 Highcharts. aesop1: Short squeeze like this TOP happens on these low floaters. The price has fallen in 5 of the last 10 days and is down by -7.